Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.

Drugs Exp Clin Res. 2000;26(5-6):285-92.Related Articles, Links Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. Korolenko TA, Poteryaeva ON, Djanayeva SJ, Svechnikova IG, Kaledin VI, Timofeyeva OA, Filipenko ML, Nowicky J. Institute of Physiology, Siberian Branch, Russian Academy of Medical Sciences, Novosibirsk, Russia. The concentration of [url=http://en.wikipedia.org/wiki/Cystatin_C]cystatin C[/url], a cysteine proteinase inhibitor, was measured during the treatment of murine [url=http://en.wikipedia.org/wiki/Lymphosarcoma]LS lymphosarcoma[/url] with [url=http://en.wikipedia.org/wiki/Cyclophosphamide]cyclophosphamide[/url] and HA-1 [url=http://]murine[/url] hepatoma with the antitumor drug Ukrain. It was shown that concentrations of cystatin C were very low in both the tumor tissues studied (HA-1 hepatoma cells and LS lymphosarcoma); increased cystatin C concentrations were found only in Ukrain-treated [url=http://en.wikipedia.org/wiki/Murine]murine[/url] hepatoma, suggesting the mechanism of antitumor effect of this drug. Cyclophosphamide treatment in LS lymphosarcoma did not influence the concentration of cystatin C in tumor cells. At the same time, a marked increase in [url=http://en.wikipedia.org/wiki/Cathepsin_B]cathepsin B[/url] and [url=http://en.wikipedia.org/wiki/Cathepsin_L]cathepsin L[/url] activity in LS lymphosarcoma was found, indicating the involvement of apoptosis in the mechanism of antitumor action of cyclophosphamide. While the DNA from untreated LS lymphosarcoma was very homogenous and its molecular weight was high, the DNA from tumors of treated mice broke down, giving rise to the ladder figure characteristically produced by cells dying from apoptosis. Evidence was obtained that cyclophosphamide-induced tumor regression was effected by apoptosis.